OPY Acquisition Corp. I

General Information

We intend to pursue targets in the life sciences industry with a primary focus on novel therapeutics, medical devices or services that help improve healthcare outcomes, areas in which our management team, directors and advisors have extensive experience. We believe that the opportunity set of potential targets is significant, and we intend to focus on assets based in the US, Europe and Israel.

Our sponsor is controlled and managed by Oppenheimer Alternative Investment Management LLC, an affiliate of Oppenheimer & Co. Inc., a global full-service brokerage and investment bank.

(OPY Acquisition Corp. I upsized its SPAC IPO at pricing on Oct. 26, 2021, to price 11 million units at $10 each to raise $110 million.)

Employees: 0
Founded: 2020
Contact Information
Address 85 Broad Street New York, New York 10004
Phone Number (212) 668-8000
Web Address
View Prospectus: OPY Acquisition Corp. I
Financial Information
Market Cap $125.0mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol OHAAU
Exchange NASDAQ
Shares (millions): 11.0
Price range $10.00 - $10.00
Est. $ Volume $110.0 mil
Manager / Joint Managers Oppenheimer & Co. / Lake Street Capital Markets
CO-Managers -
Expected To Trade: 10/27/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change